The Hologic Brevera® system represents a major leap forward in breast biopsy procedures, significantly enhancing accuracy, reducing procedure times, and improving patient comfort across all HSE-funded breast centres in Ireland. This system integrates real-time imaging with tissue acquisition, allowing clinicians to assess tissue quality in seconds, which minimizes patient wait times and enhances overall efficiency.

This nomination underscores our commitment to healthcare innovation and patient-centered solutions. HSL is proud to be recognised for our contributions to the future of diagnostic care in Ireland, and we look forward to continuing our work to bring transformative health technology to the communities we serve.

The post HSL Shortlisted for Health Tech Ireland Award for Transformative Impact in Diagnostics appeared first on Hospital Services Limited UK.

Upon receipt of the award the statement was made, as below:

“The introduction of this innovative device provides the diagnosis of HP (Helicobacter Pylori) and other neoplastic risk factors in real time during gastroscopy. Real time allows less invasive procedures: it negates the requirement for biopsies and it reduces the procedure time, benefiting the patient, with the added bonus of reduction in cost to the hospital ”.

Endofaster is working with Tallaght University Hospital in order to carry out research on 44 patients and subsequently Prof Mc Namera and her team will write a scientific paper, to be published early next year .HSL are also commencing 2 live demos over the coming weeks/months.

The post HSL win the IMSTA Annual Medtech Most Innovative Product (SME) Awards appeared first on Hospital Services Limited UK.